Clathrin Heavy Chain 1/CHC17 Antibody [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-99436PCP
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse, Rat
Predicted:
Bovine (100%), Human (100%), Rat (100%). Backed by our 100% Guarantee.
Applications
Immunohistochemistry-Paraffin, Western Blot
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Produced in rabbits immunized with a synthetic peptide corresponding to the center region of the Human Clathrin Heavy Chain 1/CHC17
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for Clathrin Heavy Chain 1/CHC17 Antibody [PerCP]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Clathrin Heavy Chain 1/CHC17
Long Name
Clathrin Heavy Chain on Chromosome 17
Alternate Names
CHC17, CLH17, CLTC, CLTCL2
Gene Symbol
CLTC
Additional Clathrin Heavy Chain 1/CHC17 Products
Product Documents for Clathrin Heavy Chain 1/CHC17 Antibody [PerCP]
Product Specific Notices for Clathrin Heavy Chain 1/CHC17 Antibody [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...